CorPath is first and only FDA-cleared robotic system for percutaneous coronary intervention (PCI)
Waltham, MA, June 26, 2014 – Corindus Vascular Robotics, the leader in precision vascular robotics, has been named the recipient of the 2014 North American New Product Innovation Award in Interventional Cardiology. The award was established by growth partnership company Frost & Sullivan to recognize visionary innovation and product excellence. Corindus’s CorPath Vascular Robotic System is the first medical device to bring robotic precision and accuracy to coronary angioplasty procedures, which may improve clinical outcomes while increasing radiation protection for interventional cardiologists.
“To achieve excellence in new product innovation leadership is not an easy task, but the CorPath system addresses a critical concern of interventional cardiologists, and has the potential to improve outcomes and economics in coronary angioplasty,” noted Greg Caressi, senior vice president, Healthcare & Life Sciences, Frost & Sullivan. “Corindus’s receipt of this award signifies a great accomplishment.”
The CorPath System stood out from other products in the market with the following key differentiators:
Corindus CEO David Handler said, “We are committed to pioneering a positive change in the delivery of healthcare and making a significant difference for patients, physicians and hospitals.
Frost & Sullivan has validated that the direction we’re moving in is the right one. On behalf of Corindus, we would like to express our thanks for this esteemed honor.”
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages more than 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath System is the first FDA-cleared medical device to bring robotic precision to interventional procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."
For additional information, visit www.corindus.com, and follow @CorindusInc.
Statements made in this release that are not statements of historical or current facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Corindus to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that includes terms such as "believes," "belief," "expects," "estimates," "intends," "anticipates" or "plans" to be uncertain and forward-looking. Forward-looking statements may include comments as to Corindus’ beliefs and expectations as to future event
Examples of such statements include statements: